Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The . gov means it’s official. Federal government websites often end in . gov or . mil VSports app下载. Before sharing sensitive information, make sure you’re on a federal government site. .

Https

The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. V体育官网.

. 2003 Jan;111(1):99-107.
doi: 10.1172/JCI16808.

A PEST sequence in ABCA1 regulates degradation by calpain protease and stabilization of ABCA1 by apoA-I

Nan Wang  1 , Wengen Chen, Patrick Linsel-Nitschke, Laurent O Martinez, Birgit Agerholm-Larsen, David L Silver, Alan R Tall
Affiliations

A PEST sequence in ABCA1 regulates degradation by calpain protease and stabilization of ABCA1 by apoA-I

Nan Wang et al. J Clin Invest. 2003 Jan.

V体育2025版 - Abstract

Cholesterol-loaded macrophage foam cells are a central component of atherosclerotic lesions. ABCA1, the defective molecule in Tangier disease, mediates the efflux of phospholipids and cholesterol from cells to apoA-I, reversing foam cell formation. In ABCA1, we identified a sequence rich in proline, glutamic acid, serine, and threonine (PEST sequence) that enhances the degradation of ABCA1 by calpain protease and thereby controls the cell surface concentration and cholesterol efflux activity of ABCA1. In an apparent positive feedback loop, apoA-I binds ABCA1, promotes lipid efflux, inhibits calpain degradation, and leads to increased levels of ABCA1. ApoA-I infusion also increases ABCA1 in vivo. These studies reveal a novel mode of regulation of ABCA1 by PEST sequence-mediated calpain proteolysis that appears to be reversed by apolipoprotein-mediated phospholipid efflux. Inhibition of ABCA1 degradation by calpain could represent a novel therapeutic approach to increasing macrophage cholesterol efflux and decreasing atherosclerosis. VSports手机版.

PubMed Disclaimer

Figures (V体育官网)

Figure 1
Figure 1
A PEST sequence regulates the cell surface expression and function of ABCA1. (a) Schematic model of ABCA1 showing the location and amino acid sequence of the PEST sequence in mouse (m), human (h), and chicken (c). The PEST score is +16.42, as determined by PESTfind. (b) Levels of total (bottom) and cell surface (top, biotinylated) ABCA1 and ABCA1delPEST in transiently transfected HEK293 cells. (c, f, and g) DNA dose-dependent ABCA1-mediated and ABCA1delPEST-mediated cellular cholesterol efflux (c), phospholipid efflux (f), and apoA-I cell association (g). (d) Total cellular ABCA1 protein mass as determined by quantitative Western blotting in the cholesterol efflux assay. (e) Cholesterol efflux efficiency determined by percentage efflux normalized for total cellular ABCA1 protein mass. (h) Levels of total (bottom) and ubiquitinated (top) ABCA1 and ABCA1delPEST in HEK293 cells incubated with or without lactacystin (20 μM) for 3 hours. The data are representative of two experiments (c and e–h, triplicate; d, duplicate) or three experiments (b, duplicate and triplicate) with similar results.
Figure 2
Figure 2
Calpain protease catalyzes PEST-dependent degradation of ABCA1. (a) Levels of ABCA1 and ABCA1delPEST in 293 cells, incubated with or without calpeptin (30 μg/ml) for 3 hours, as determined by Western blot analysis. (b) Cell surface ABCA1 or ABCA1delPEST in 293 cells with or without incubation with calpeptin (20 μg/ml) for 3 hours, as determined by biotinylation, immunoprecipitation with anti-FLAG antibody, and Western analysis with avidin–horseradish peroxidase. The data are representative of two experiments, each performed in triplicate, with similar results. (c and d) The susceptibility to exogenously added μ-calpain of ABCA1 or ABCA1delPEST metabolically labeled by [35S]methionine in digitonin-permeabilized 293 cells with (d) or without (c) pretreatment with apoA-I (10 μg/ml) for 3 hours.
Figure 3
Figure 3
Calpeptin increases ABCA1 in primary mouse macrophages and hepatocytes. Levels of ABCA1 in mouse peritoneal macrophages (a) or primary mouse hepatocytes (b) incubated with or without calpeptin at indicated concentration for 3 hours. The data are representative of three independent experiments with similar results.
Figure 4
Figure 4
ApoA-I–mediated increase in ABCA1 requires PEST sequence. (a) Dose-response effect of apoA-I (3 hours’ incubation) in HEK293 cells transfected with wild-type ABCA1. (b) Wild-type ABCA1 and ABCA1delPEST protein levels after 3 hours of incubation with apoA-I (10 μg/ml) in 293 cells transiently transfected with the FLAG-tagged constructs, as determined by Western blot with FLAG antibodies. The data are representative of three (a) or two (b) experiments with similar results.
Figure 5
Figure 5
Effects of cholesterol and phospholipid efflux on the induction of ABCA1 by apoA-I. (a, top) ABCA1 protein level in mouse peritoneal macrophages after 3 hours of incubation with 10 μg/ml apoA-I or 50 μg/ml HDL2, or after pretreatment with 1 mM methyl-β-cyclodextrin (MβCD) for 5 minutes to deplete cholesterol and then with control media for 3 hours. (a, bottom) Phospholipid (Pl) and cholesterol (Ch) efflux in macrophages treatments similar to those in the top panel. (b) ABCA1-FLAG and Walker-mutant (K939M) ABCA1-FLAG (ABCA1WM) protein levels after 3 hours of incubation with apoA-I (10 μg/ml) in transiently transfected 293 cells. (c) Wild-type ABCA1-FLAG and ABCA1-W590S-FLAG protein levels after 3 hours of incubation with apoA-I (10 μg/ml) or calpeptin (20 μg/ml) in 293 cells. The data are representative of two (a and b) or three (c) experiments with similar results.
Figure 6
Figure 6
ApoA-I and apoE increase ABCA1 protein in mouse primary hepatocytes and macrophages. (a) Time course of the effect of apoA-I (10 μg/ml) on ABCA1 protein levels in mouse peritoneal macrophages pretreated overnight with 50 μg/ml acetyl-LDL and LXR/RXR ligands 22(R)-hydroxycholesterol and 9-cis retinoic acid (RA) (both 10 μM). (b) Cell surface biotinylated ABCA1 levels in macrophages after 3 hours of incubation with 10 μg/ml apoA-I. (c) ABCA1 levels in primary mouse hepatocytes incubated for 3 hours with 10 μg/ml apoA-I. (d) Effects of apoA-I (10 μg/ml) on ABCA1 levels in macrophages treated with or without acetyl-LDL (AcLDL) and LXR/RXR ligands. (e) Dose response of apoE3 effect (3 hours’ incubation) on ABCA1 protein levels in mouse peritoneal macrophages pretreated with acetyl-LDL, 22(R)-hydroxycholesterol, and 9-cis retinoic acid. (f) ABCA1 levels in mouse peritoneal macrophages after 3 hours of incubation with or without apoE3 (10 μg/ml). (g) ABCA1, W590S-ABCA1, and ABCA1delPEST protein levels in HEK293 cells after 3 hours of incubation with or without apoE3. The data are representative of two (a, b, e, and g) or three (c, d, and f) experiments with similar results.
Figure 7
Figure 7
ApoA-I injection increases ABCA1 protein in hepatocytes and macrophages in mice. (a) Hepatic ABCA1 levels in mice 4 hours after intravenous injection of apoA-I (20 mg/kg body weight) or albumin as control (Ctr). The bar graph represents quantification of ABCA1 protein levels normalized against β-actin (n = 5 for each group, P < 0.01). (b) Macrophage ABCA1 levels in mice 4 hours after apoA-I injection (n = 5 for apoA-I group and n = 3 for control group, P < 0.006).
See this image and copyright information in PMC

VSports - References

    1. Brown MS, Ho YK, Goldstein JL. The cholesteryl ester cycle in macrophage foam cells. Continual hydrolysis and re-esterification of cytoplasmic cholesteryl esters. J. Biol. Chem. 1980;255:9344–9352. - V体育2025版 - PubMed
    1. Ho YK, Brown MS, Goldstein JL. Hydrolysis and excretion of cytoplasmic cholesteryl esters by macrophages: stimulation by high density lipoprotein and other agents. J. Lipid Res. 1980;21:391–398. - PubMed
    1. Oram JF, Albers JJ, Cheung MC, Bierman EL. The effects of subfractions of high density lipoprotein on cholesterol efflux from cultured fibroblasts. Regulation of low density lipoprotein receptor activity. J. Biol. Chem. 1981;256:8348–8356. - PubMed
    1. Rubin EM, Krauss RM, Spangler EA, Verstuyft JG, Clift SM. Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI. Nature. 1991;353:265–267. - "V体育2025版" PubMed
    1. Plump AS, Scott CJ, Breslow JL. Human apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse. Proc. Natl. Acad. Sci. USA. 1994;91:9607–9611. - PMC - PubMed

Publication types

"VSports注册入口" MeSH terms

Substances